D 5. 8 Efficacy of biochemical therapies conjugated to graphene materials in vivo

This report will update on the use of graphene materials alone or conjugated to therapeutic agents to treat i) epilepsy, ii) anxiety and iii) Parkinson’s disease in vivo.